OneOncology, LLC, headquartered in the United States, is a leading player in the oncology services industry, dedicated to transforming cancer care. Founded in 2018, the company has rapidly expanded its footprint across major operational regions, providing innovative solutions that enhance patient outcomes. Specialising in community-based cancer care, OneOncology offers a unique model that integrates advanced treatment options with personalised support services. This approach not only improves access to cutting-edge therapies but also fosters a compassionate environment for patients and their families. With a commitment to excellence, OneOncology has established itself as a trusted partner for oncology practices, achieving significant milestones in operational efficiency and patient satisfaction. As a pioneer in the field, OneOncology continues to set the standard for quality cancer care across the nation.
How does OneOncology, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
OneOncology, LLC's score of 31 is higher than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
OneOncology, LLC, headquartered in the US, currently does not have specific carbon emissions data available, as indicated by the absence of reported figures. The company is a current subsidiary of TPG Inc., which may influence its climate commitments and emissions reporting. As of now, OneOncology has not established any documented reduction targets or climate pledges. The lack of specific emissions data and reduction initiatives suggests that the company is in the early stages of developing its climate strategy. Given the context of its parent company, TPG Inc., OneOncology may benefit from broader sustainability initiatives and frameworks that TPG has in place. However, without explicit data or commitments from OneOncology itself, it is challenging to provide a detailed overview of its carbon emissions and climate commitments.
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Scope 1 | 2,478,320 | 000,000 | 000,000 | 000,000 | 000,000 |
| Scope 2 | 1,906,400 | 0,000,000 | 000,000 | 000,000 | 0,000,000 |
| Scope 3 | 14,679,280 | 0,000,000 | 0,000,000 | 00,000,000 | 00,000,000 |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
OneOncology, LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.